Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ep 24332
2. Ep-24332
1. 151272-78-5
2. D19v7048jk
3. Ep 24332
4. Ep-24332
5. Ac-d-nal-d-cpa-d-pal-ser-tyr-d-hci-leu-lys(ipr)-pro-d-ala-nh2
6. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-l-tyrosyl-n6-(aminocarbonyl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-
7. D-23234
8. Teverelixum
9. Refchem:188970
10. (2s)-1-((2s)-2-(((2s)-2-(((2r)-2-(((2s)-2-(((2s)-2-(((2r)-2-(((2r)-2-(((2r)-2-acetamido-3-naphthalen-2-ylpropanoyl)amino)-3-(4-chlorophenyl)propanoyl)amino)-3-pyridin-3-ylpropanoyl)amino)-3-hydroxypropanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-6-(carbamoylamino)hexanoyl)amino)-4-methylpentanoyl)amino)-6-(propan-2-ylamino)hexanoyl)-n-((2r)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide
11. Teverelix [inn]
12. Unii-d19v7048jk
13. D 23234
14. Orb1699148
15. Dtxsid301033772
16. N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-l-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-l-tyrosyl-n6-(aminocarbonyl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-d-alaninamide
17. Akos040749635
18. Db05624
19. Hy-105173
20. Cs-0025196
21. Q27275967
22. N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-l-tyrosyl-n6-(aminocarbonyl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-d-alaninamide
23. N-acetyl-3-(2-naphthyl)-d-alanyl-p-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-l-tyrosyl-n(sup 6)-carbamoyl-d-lysyl-l-leucyl-n(sup 6)-isopropyl-l-lysyl-l-prolyl-d-alaninamide
| Molecular Weight | 1459.1 g/mol |
|---|---|
| Molecular Formula | C74H100ClN15O14 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 15 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 41 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 446 |
| Heavy Atom Count | 104 |
| Formal Charge | 0 |
| Complexity | 2810 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in benign prostatic hyperplasia, endometriosis, and prostate cancer.
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
Teverelix is a GnRH (Gonadotropin releasing hormone) antagonist.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
99
PharmaCompass offers a list of Teverelix API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Teverelix manufacturer or Teverelix supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teverelix manufacturer or Teverelix supplier.
A Teverelix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Teverelix, including repackagers and relabelers. The FDA regulates Teverelix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Teverelix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Teverelix supplier is an individual or a company that provides Teverelix active pharmaceutical ingredient (API) or Teverelix finished formulations upon request. The Teverelix suppliers may include Teverelix API manufacturers, exporters, distributors and traders.
Teverelix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Teverelix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Teverelix GMP manufacturer or Teverelix GMP API supplier for your needs.
A Teverelix CoA (Certificate of Analysis) is a formal document that attests to Teverelix's compliance with Teverelix specifications and serves as a tool for batch-level quality control.
Teverelix CoA mostly includes findings from lab analyses of a specific batch. For each Teverelix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Teverelix may be tested according to a variety of international standards, such as European Pharmacopoeia (Teverelix EP), Teverelix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Teverelix USP).
